These results suggest that specific dominant HER2iR RTKs or their downstream signaling nodes control the activity of CDK7/RNA pol II complex and drive CDK7 mediated transcription activation in each individual HER2iR breast cancer cell line (Fig. 5d and Supplementary Fig. S13). This evidence concerns the gene CDK7 and breast cancer.